Document is current
Any future updates will be listed below
-
Authors
Auvinen, P.
Vehviläinen, J.
Marjonen, H.
Modhukur, V.
Sokka, J.
Wallén, E.
Rämö, K.
Ahola, L.
Salumets, A.
Otonkoski, T.
Skottman, H.
Ollikainen, M.
Trokovic, R.
Kahila, H.
Kaminen-Ahola, N. http://orcid.org/0000-0003-1255-4716
-
Funding
Funding for this research was provided by:
Academy of Finland (332212, 297466, 312437, 297886, 297908, 328685)
Helsingin Yliopisto (early career investigator funding)
Alkoholitutkimussäätiö
Yrjö Jahnssonin Säätiö
Juho Vainion Säätiö
Paulon Säätiö
Suomen Kulttuurirahasto (00190186, 00200185, 00212573)
Estonian Research Council (PRG1076)
H2020 Innovation (ERIN, EU952516)
European Commission and Enterprise Estonia (EU48695)
Jane ja Aatos Erkon Säätiö
Center of Excellence in Stem Cell Metabolism
Sigrid Juséliuksen Säätiö
- License Information
-
More Information
Article History
Received: 25 July 2022
Accepted: 7 December 2022
First Online: 30 December 2022
Declarations
:
: Informed consent was obtained from all participants and the study was approved by the Ethics Committee of Helsinki University Central Hospital (386/13/03/03/2012). hESC cell line H1 (WA01) was obtained from Biomedicum Stem Cell Center (BSCC, Helsinki, Finland) through a license agreement with WiCell, Inc. and Regea08/017 from Skottman laboratory (Tampere, Finland) approved by the Ethics Committee of Tampere University Hospital (Skottman/R05116).
: The authors declare that they have no competing interests.
